Vertex Advances Kidney Disease Drug into Phase 3 Trial
Key Highlights Inaxaplin enters Phase 3 of its pivotal trial, focusing on AMKD patients, including adolescents aged 10 to…
Browsing Tag
Stanford University School of Medicine
1 post